Background publications
|
Gregory, Dendrou, Attfield, Haghikia, Xifara, Butter, Poschmann, Kaur, Lambert, Leach, Prömel, Punwani, Felce, Davis, Gold, Nielsen, Siegel, Mann, Bell, McVean, Fugger: "TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis." in: Nature, Vol. 488, Issue 7412, pp. 508-11, 2012 (PubMed).
Le, Trilling, Hengel: "The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-? signaling." in: Journal of virology, Vol. 85, Issue 24, pp. 13260-70, 2011 (PubMed).
Jiang, Woronicz, Liu, Goeddel: "Prevention of constitutive TNF receptor 1 signaling by silencer of death domains." in: Science (New York, N.Y.), Vol. 283, Issue 5401, pp. 543-6, 1999 (PubMed).
|